Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay-Reference-Cited by-同舟云学术

Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay

Published:2016-03-16 Issue:17 Volume:7 Page:23569-23580
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jia Kun¹,Li Wei¹,Wang Feng²,Qu Haixia²,Qiao Yuanyuan³,Zhou Lanping¹,Sun Yulin¹,Ma Qingwei²,Zhao Xiaohang¹

Affiliation:

1. State Key Laboratory of Molecular Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

2. Bioyong Technologies Inc., Beijing 100080, China

3. Center for Basic Medical Sciences, Navy General Hospital, Beijing 100048, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of variation of serum CEA, SCC, CYFRA21-1 in patients with lung cancer and their diagnostic value with EBUS-TBNA;Journal of Medical Biochemistry;2023-11-25

2. Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy;Frontiers in Oncology;2022-10-21

3. Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia;Frontiers in Cardiovascular Medicine;2022-10-11

4. Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer;Cells;2022-03-11

5. Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients;OncoTargets and Therapy;2021-02